Biotech · Private company · Boston, MA, US
Adeptrix Corporation
Track this companyFree. Adds Adeptrix Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- TauTrace™: An ultrasensitive immunoassay for neurodegenerative protein biomarkersFiscal year 2025 · $499.9KNIH RePORTER 1R43AG094422-01 · fetched Nov 12, 2026
- Immunoassay for Measuring Mutation Activated Kinases Across Multiple Cell Signaling PathwaysFiscal year 2024 · $295.2KNIH RePORTER 1R43CA291535-01 · fetched Nov 12, 2026